ARYX THERAPEUTICS INC (ARYX)

Overview Price 0.01 Price Change Today 0.00 (0.00%) P&P rating Zacks Rank N/A - N/A Open Price $0.00 Previous Close $0.01 Daily Range $0.00 - $0.00 52-Week Range $0.01 - $0.04 Volume 0 ARYx Therapeutics is a biopharmaceutical company focused on developing a portfolio of internally discovered product candidates designed to eliminate known safety issues associated with well-established, commercially successful drugs. ARYx uses its RetroMetabolic Drug Design(TM) technology to design structurally unique molecules that retain the efficacy of these original drugs but are metabolized through a potentially safer pathway to avoid specific adverse side effects associated with these compounds. ARYx currently has three products in Phase 2 clinical trials: ATI-7505 for the treatment of various gastrointestinal disorders, ATI-5923 for the treatment of patients at risk for the formation of dangerous blood clots, and ATI-2042 for the treatment of atrial fibrillation. Other Resources for ARYX Detailed Quote Earnings Estimates Company Report Interactive Chart Commentary No Commentary Found for This Ticker. ARYx Therapeutics is a biopharmaceutical company focused on developing a portfolio of internally discovered product candidates designed to eliminate known safety issues associated with well-established, commercially successful drugs. ARYx uses its RetroMetabolic Drug Design(TM) technology to design structurally unique molecules that retain the efficacy of these original drugs but are metabolized through a potentially safer pathway to avoid specific adverse side effects associated with these compounds. ARYx currently has three products in Phase 2 clinical trials: ATI-7505 for the treatment of various gastrointestinal disorders, ATI-5923 for the treatment of patients at risk for the formation of dangerous blood clots, and ATI-2042 for the treatment of atrial fibrillation.   No brokerage coverage for ARYX   ARYX Ratings: BUY  SELL  HOLD ARYX Consensus Forecasts

Rate this Stock! You haven't rated this stock yet! Ticker Call Buy Sell Analysis Time Frame Week or Less Week to a Month One to Three Months Three to Six Months Six Months to a Year One to Three Years Three Plus Years What The Community Thinks Total Players 1 Buy 0 Sell   Top Buy Analysis No Buy Analysis. Be the First. More Recent Analysis Top Sell Analysis No Sell Analysis. Be the First. More Recent Analysis

Blog Posts

User	User Score	Date	Title	Comments	Last Comment
uwpltre	92.56	03/26/10	RW Evolution in progress	1	03/27/10

Commentary

BUY: ARYX THERAPEUTICS INC. (ARYX) Start Price: $7.90 Points: -89.61 Created: 01/01/2008 Comments: 0 | Comment Chinapolicy Recs:

Picks

Username	P&P Score	Call	Time Frame	Start Date	Start Price	Today (change)	Stock Gain	S&P Gain	Points	Analysis
Chinapolicy	32.01	BUY	Six Months to a Year	01/01/2008	$7.90	$0.01 (-12.50%)	-99.87%	-10.25%	-89.61